By 2015 the HIV
market will balloon to $10.6 billion, in part because of
new drugs from Merck, Tibotec, and Pfizer, reports
ScientificAmerican.com. The market was worth around $7.1
billion in 2005 and will be changing significantly as
new classes of drugs are introduced.
analyst at the firm Datamonitor, said, "We're expecting
the market to grow to about $10 billion in the next 10
years, despite patent expires for several key HIV
drugs." The expected growth will come largely from new
drugs being launched.
that while pharmaceutical companies are pressured to
slash prices for drugs in the developing world, selling HIV
drugs in the West is a highly profitable business.
released a report last month stating that the global
pharmaceutical market grew 7% in 2006, to $643 billion.